80/100BMarsh & McLennan Companies stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Marsh & McLennan Companies is 206.00, 0.8% below the current price of 207.71. Their targets range from 182.00 to 234.00.
Of the 15 firms that rated Marsh & McLennan Companies in the past 12 months, 7 rate it buy or strong buy, 7 hold and 1 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 182.00 to 234.00, with an average of 206.00.
| Buy | 7 | |
| Hold | 7 | |
| Sell | 1 |
12-month price target
| Highest target | 234.00 |
| Average target | 206.00 |
| Lowest target | 182.00 |
| Current price | 207.71 |
Marsh & McLennan Companies price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Marsh & McLennan Companies price target and rating?
How analysts rate Marsh & McLennan Companies, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
7 of 15 firms rate it buy now, against 4 of 11 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Marsh & McLennan Companies analyst upgrades, downgrades and price targets
The latest rating change came on 3 November 2026, when BMO Capital upgraded Marsh & McLennan Companies from Market Perform to Outperform. The most recent new target came from J.P. Morgan on 20 October 2026: 218.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 3 Nov 2026 | BMO Capital | Upgraded · Market Perform → Outperform | — | — | — |
| 20 Oct 2026 | J.P. Morgan Pablo Singzon | — | 218.00 | — | 191.26 |
| 19 Oct 2026 | Mizuho Securities | Reiterated · Neutral | 190.00 → 200.00 | +5.3% | 188.35 |
| 17 Oct 2026 | KBW Meyer Shields | — | 201.00 | — | 188.35 |
| 16 Oct 2026 | Wells Fargo | Reiterated · Equal Weight | 188.00 → 197.00 | +4.8% | 186.54 |
| 16 Oct 2026 | Citigroup Matthew Heimermann | Reiterated · Neutral | 203.00 | — | 188.35 |
| 7 Oct 2026 | Mizuho Securities | Reiterated · Neutral | 201.00 → 190.00 | -5.5% | 171.75 |
| 6 Oct 2026 | UBS | Reiterated · Buy | 216.00 → 222.00 | +2.8% | 170.43 |
| 25 Aug 2026 | BMO Capital | — | 203.00 | — | 194.67 |
| 19 Aug 2026 | Morgan Stanley | Reiterated · Equal Weight | 180.00 → 200.00 | +11.1% | 186.37 |
| 27 Jul 2026 | UBS | Reiterated · Buy | 212.00 → 216.00 | +1.9% | 184.63 |
| 22 Jul 2026 | Mizuho Securities Yaron Kinar | Reiterated · Neutral | 197.00 → 201.00 | +2.0% | 181.59 |
| 22 Jul 2026 | Wells Fargo | Reiterated · Equal Weight | 199.00 → 188.00 | -5.5% | 181.59 |
| 22 Jul 2026 | Citigroup | Downgraded · Buy → Neutral | — | — | — |
| 21 Jul 2026 | Morgan Stanley | — | 175.00 → 180.00 | +2.9% | 182.22 |
| 10 Jul 2026 | Evercore ISI | Reiterated · Outperform | 236.00 → 234.00 | -0.8% | 179.91 |
| 9 Jul 2026 | Mizuho Securities | Reiterated · Neutral | 193.00 → 197.00 | +2.1% | 179.05 |
| 8 Jul 2026 | UBS | Reiterated · Buy | 203.00 → 212.00 | +4.4% | 177.18 |
| 6 Jul 2026 | Morgan Stanley | Reiterated · Equal Weight | 190.00 → 175.00 | -7.9% | 178.54 |
| 9 Jun 2026 | UBS Brian Meredith | Reiterated · Buy | 180.00 → 203.00 | +12.8% | 162.52 |
| 26 May 2026 | Piper Sandler | Reiterated · Neutral | 182.00 | — | 164.11 |
| 21 May 2026 | UBS | — | 257.00 → 180.00 | -30.0% | 163.38 |
| 6 May 2026 | Citigroup | Upgraded · Neutral → Buy | — | — | — |
| 13 Apr 2026 | Mizuho Securities | Reiterated · Neutral | 213.00 → 193.00 | -9.4% | 171.93 |
| 27 Feb 2026 | Mizuho | Downgraded · Outperform → Neutral | — | — | — |
| 17 Feb 2026 | Raymond James Strong Buy | Upgraded · Outperform → Strong Buy | 225.00 | — | 174.06 |
| 2 Feb 2026 | Cantor Fitzgerald | Reiterated · Overweight | 208.00 → 212.00 | +1.9% | 190.46 |
| 2 Feb 2026 | Mizuho Securities | — | 212.00 → 213.00 | +0.5% | 188.19 |
| 14 Jan 2026 | Cantor Fitzgerald | Reiterated · Overweight | 256.00 → 208.00 | -18.8% | 182.70 |
| 13 Jan 2026 | Wells Fargo Elyse Greenspan | Reiterated · Equal Weight | 212.00 → 199.00 | -6.1% | 185.63 |
| 8 Jan 2026 | Barclays Alex Scott | Reiterated · Overweight | 206.00 → 210.00 | +1.9% | 182.90 |
| 7 Jan 2026 | Goldman Sachs Robert Cox | — | 195.00 → 199.00 | +2.1% | 182.90 |
| 7 Jan 2026 | Evercore ISI | Reiterated · Outperform | 237.00 → 236.00 | -0.4% | 182.65 |
| 16 Dec 2025 | Morgan Stanley Bob Huang | — | 195.00 → 190.00 | -2.6% | 187.29 |
| 15 Dec 2025 | Mizuho Securities | — | 212.00 | — | 187.29 |
| 24 Nov 2025 | RBC Capital | — | 200.00 | — | 179.28 |
| 20 Nov 2025 | Barclays Alex Scott | Upgraded · Equal Weight → Overweight | 221.00 → 206.00 | -6.8% | 177.13 |
Marsh & McLennan Companies EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Marsh & McLennan Companies's EPS to grow 14.3% a year until 2028, about as fast as over the last 5 years (16.4% a year) and the last 3 years (11.8%).
Analysts expect Marsh & McLennan Companies's revenue to grow 5.6% a year until 2028, slower than over the last 5 years (9.4% a year) and the last 3 years (9.2%).
Revenue
EPS
Does Marsh & McLennan Companies beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 3.0% off the result, either way, and their revenue estimate 1.2%, over the last 12 quarters.
- EPS beats
- 89 / 136
- Revenue beats
- 78 / 119
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +3.0%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 15 Oct 2026 | 1.97 | 2.03 | +3.0% | 6.64B | 6.86B | +3.3% |
| Q2 FY2026 | 21 Jul 2026 | 2.90 | 2.96 | +2.1% | 7.28B | 7.40B | +1.7% |
| Q1 FY2026 | 16 Apr 2026 | 3.22 | 3.29 | +2.2% | 7.41B | 7.60B | +2.6% |
| Q4 FY2025 | 29 Jan 2026 | 1.97 | 2.12 | +7.6% | 6.56B | 6.60B | +0.6% |
| Q3 FY2025 | 16 Oct 2025 | 1.78 | 1.85 | +3.9% | 6.32B | 6.35B | +0.4% |
| Q2 FY2025 | 17 Jul 2025 | 2.67 | 2.72 | +1.9% | 6.94B | 6.97B | +0.5% |
| Q1 FY2025 | 17 Apr 2025 | 3.02 | 3.06 | +1.3% | 7.08B | 7.06B | -0.2% |
| Q4 FY2024 | 30 Jan 2025 | 1.76 | 1.87 | +6.3% | 5.96B | 6.07B | +1.8% |
| Q3 FY2024 | 17 Oct 2024 | 1.61 | 1.63 | +1.2% | 5.71B | 5.70B | -0.2% |
| Q2 FY2024 | 18 Jul 2024 | 2.40 | 2.41 | +0.4% | 6.31B | 6.22B | -1.3% |
| Q1 FY2024 | 18 Apr 2024 | 2.80 | 2.89 | +3.2% | 6.38B | 6.47B | +1.4% |
| Q4 FY2023 | 25 Jan 2024 | 1.63 | 1.68 | +3.1% | 5.54B | 5.55B | +0.3% |
Marsh & McLennan Companies stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Marsh & McLennan Companies's earnings keep growing at the 8.9% a year analysts expect to FY2028, it would earn about 14.92 a share in FY2030. At the P/E it has traded at over the last five years (21.9 to 28.0) that is 326.38 to 418.25 a share, or 379.01 at its average P/E of 25.4. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 10.49 | 229.47 | 266.47 | 294.06 |
| FY2027 | 11.46 | 250.81 | 291.25 | 321.40 |
| FY2028 | 12.58 | 275.32 | 319.71 | 352.81 |
| FY2029 (extrapolated) | 13.70 | 299.76 | 348.10 | 384.14 |
| FY2030 (extrapolated) | 14.92 | 326.38 | 379.01 | 418.25 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 8.9% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (21.9, 25.4, 28.0).
Is Marsh & McLennan Companies stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Marsh & McLennan Companies's P/E of 24.8 is around the middle of its 5-year range (19.6 to 32.6, median 25.3). It is in line with its own history. Buyers pay about the usual price for each point of growth: a PEG of 1.7 on expected growth against 1.5 on its median P/E and past five years' growth. At its usual P/E (25.3 × EPS of 8.39), Marsh & McLennan Companies's fair value is 211.86, close to the price of 207.71. Its forward P/E, on the consensus for FY2026, is 19.8.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (19.6 and 32.6). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 24.76
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 25.25
- Five-year P/E range
- 19.6 – 32.6
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 19.80
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 2.79
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- -0.8%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.760 | 71.4258Price 35.76193 | +99.7% | |
| 29.080 | 56.2434Price 29.0896 | +93.4% | |
| 240.360 | 464.26205Price 240.36627 | +93.2% | |
| 202.040 | 384.58163Price 202.042,644 | +90.3% | |
| 161.340 | 305.52160Price 161.34396 | +89.4% | |
| 125.395 | 237.44178Price 125.40297 | +89.4% | |
| 159.580 | 300.48225Price 159.58376 | +88.3% |
Furthest below the fair value on each stock's page, updated every day.